pindolol has been researched along with Neurotic Disorders in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oswald, WD | 1 |
| Kenedi, I | 1 |
1 trial available for pindolol and Neurotic Disorders
| Article | Year |
|---|---|
[Anxiolysis and reduction of subjectively scaled "strain" in cognitive stress by means of pindolol].
Topics: Adult; Anxiety; Chlordiazepoxide; Drug Evaluation; Humans; Neurotic Disorders; Pindolol; Placebos; S | 1980 |
1 other study available for pindolol and Neurotic Disorders
| Article | Year |
|---|---|
[Diagnostic importance of visken -- an adrenergic beta receptor blocking agent].
Topics: Adolescent; Adult; Cardiac Complexes, Premature; Coronary Disease; Electrocardiography; Female; Hear | 1975 |